THROMBOCYTOPENIA PREVALENCE AND SEVERITY ASSESSMENT IN PLASMODIUM VIVAX MALARIA PATIENTS
Main Article Content
Keywords
Anemia, Malaria, Plasmodium Vivax, Thrombocytopenia
Abstract
Background: Thrombocytopenia, characterized by reduced platelet counts, is a known consequence of various malaria infections. Nevertheless, its occurrence and clinical significance in Plasmodium vivax malaria have received limited attention. While thrombocytopenia and anemia are frequently observed abnormalities, this study aims to assess thrombocytopenia in Plasmodium vivax malaria patients, providing insights into the risk of severe thrombocytopenia.
Methodology: This descriptive cross-sectional study was carried out at Hayatabad Medical Complex in Peshawar, Pakistan. A total of 297 cases were included in the study using a consecutive non-probability sampling method. Patients of both genders between ages 18 to 60 years, with smear-positive VIVAX malaria who had a fever exceeding 100 degrees Fahrenheit for at least one day were included. Confounding factors were managed through strict adherence to exclusion criteria.
Result: Thrombocytopenia was highly prevalent among Vivax Malaria patients, affecting 82.83% of cases, with 17.17% remaining unaffected. Most patients experienced mild or moderate thrombocytopenia, while severe cases were rare (1.35%). Analysis by age revealed a slight increase in older patients. Prevalence of thrombocytopenia was 80.9% for ≤30 years, 81.4% for 31-40 years, 84.5% for 41-50 years, and 89.5% for >50 years. Gender-based analysis showed a slightly higher prevalence in females (83.2%) versus males (82.6%), though not statistically significant.
Conclusion: These findings highlight the importance of monitoring platelet counts and comprehending the clinical significance of thrombocytopenia in vivax malaria management. Further research is needed to gain a comprehensive understanding of the underlying mechanisms and clinical implications of thrombocytopenia in vivax malaria.
References
2. Awoke N, Arota A. Profiles of hematological parameters in plasmodium falciparum and plasmodium vivax malaria patients attending tercha general hospital, Dawuro zone, south Ethiopia. Infect Drug Resist. 2019;12:521–7.
3. Cruz-Coke R. Mendel en la historia de la medicina. Vol. 101, Revista medica de Chile. 1973. 252–256 p.
4. Singh B, Daneshvar C. Human infections and detection of plasmodium knowlesi. Clin Microbiol Rev. 2013;26(2):165–84.
5. RESEARCH PAPERS CLASSIFICATION OF Plasmodium SPECIES IN MALARIA INFECTED BLOOD CELL IMAGES AND. 2021;10(1):2021.
6. Khan MI, Qureshi H, Bae SJ, Khattak AA, Anwar MS, Ahmad S, et al. Malaria prevalence in Pakistan: A systematic review and meta-analysis (2006–2021). Heliyon [Internet]. 2023;9(4):e15373. Available from: https://doi.org/10.1016/j.heliyon.2023.e15373
7. World Health Organization. Global technical strategy for malaria 2016–2030. World Heal Organ [Internet]. 2016;1–35. Available from: https://apps.who.int/iris/bitstream/handle/10665/186671/9789243564999_spa.pdf?sequence=1
8. Lacerda MV, Mourão MP, Alexandre MA, Siqueira AM, Magalhães BM, Martinez-Espinosa FE, et al. Understanding the clinical spectrum of complicated Plasmodium vivax malaria: A systematic review on the contributions of the Brazilian literature. Malar J. 2012;11:1–18.
9. Ampadu HH, Asante KP, Bosomprah S, Akakpo S, Hugo P, Gardarsdottir H, et al. Prescribing patterns and compliance with World Health Organization recommendations for the management of severe malaria: A modified cohort event monitoring study in public health facilities in Ghana and Uganda. Malar J [Internet]. 2019;18(1):1–8. Available from: https://doi.org/10.1186/s12936-019-2670-9
10. Antonelli LR, Junqueira C, Vinetz JM, Golenbock DT, Ferreira MU, Gazzinelli RT. The immunology of Plasmodium vivax malaria. Immunol Rev. 2020;293(1):163–89.
11. Aggarwal S, Peng WK, Srivastava S. Multi-omics advancements towards Plasmodium vivax malaria diagnosis. Diagnostics. 2021;11(12).
12. Beeson JG, Chu CS, Richards JS, Nosten F, Fowkes FJI. Plasmodium vivax malaria: Challenges in diagnosis, treatment and elimination. Pediatr Infect Dis J. 2015;34(5):529–31.
13. Hurt AC, Barr IG. Rapid diagnostic tests for influenza. Revolutionizing Trop Med Point-of-Care Tests, New Imaging Technol Digit Heal. 2019;191–201.
14. Fitri LE, Widaningrum T, Endharti AT, Prabowo MH, Winaris N, Nugraha RYB. Malaria diagnostic update: From conventional to advanced method. J Clin Lab Anal. 2022;36(4):1–14.
15. Ferreira MU, Nobrega de Sousa T, Rangel GW, Johansen IC, Corder RM, Ladeia-Andrade S, et al. Monitoring Plasmodium vivax resistance to antimalarials: Persisting challenges and future directions. Int J Parasitol Drugs Drug Resist. 2021;15(October 2020):9–24.
16. Arif M, Jelia S, Meena S, Meena S, Jain P, Ajmera D, et al. A study of thrombocytopenia in malaria and its prognostic significance. Int J Res Med Sci. 2016;4(6):2373–8.
17. Martínez-Salazar EL, Tobón-Castaño A. Platelet profi le is associated with clinical complications in patients with vivax and falciparum malaria in Colombia. Rev Soc Bras Med Trop. 2014;47(3):341–9.
18. Gopalakrishnan NT, Papaiah S, Soman S, Upadhyaya K. A Clinicopathological Study of Thrombocytopenia in Malaria Cases with Its Evaluation in Different Types of Malaria. 2021;10(33):2–6.
19. Iqbal S, Sardar J, Khan HA, Abbas G, Mehmood B, Khan BS. ANALYSIS OF HAEMATOLOGICAL COMPLICATIONS IN VIVAX AND FALCIPARUM MALARIA IN IN-DOOR PATIENTS IN A TERTIARY CARE HOSPITAL IN PAKISTAN. 2023;31(2):149–52.
20. Article O, Waseem N, Nasir H, Hassan KA. FREQUENCY OF THROMBOCYTOPENIA IN CONFIRMED CASES OF. 2023;34(02):103–6.
21. Hanson J, Phu NH, Hasan MU, Charunwatthana P, Plewes K, Maude RJ, et al. The clinical implications of thrombocytopenia in adults with severe falciparum malaria: A retrospective analysis. BMC Med. 2015;13(1):1–9.
22. Ullah I, Zeb MA, Ullah A, Jamal SF, Khan MA. Original Article Hematological Profile of Plasmodium Vivax and Plasmodium Falciparum Infected Patients Compared With Control Group in Hayatabad Medical Complex , Peshawar. Ann Allied Heal Sci. 2021;Vol. 07, N:21–6.
23. Idrees F, Reporting M, Words K. Pakistan journal of health sciences. 2022;(c):2017–8.
24. Darraj MA. Clinical Profile of Severe Plasmodium falciparum and P . vivax Malaria in Jazan Region , Saudi Arabia. 2020;16(11):73–80.
25. Choudhary PK, Mainali N. Interpretation on coexistence or association of thrombocytopenia with malaria. 2019;9:1453–6.
26. Anvikar AR, Maria A, Eijk V, Shah A, Upadhyay KJ, Sullivan SA. Clinical and epidemiological characterization of severe Plasmodium vivax malaria in Gujarat , India. Virulence [Internet]. 2020;11(1):730–8. Available from: https://doi.org/10.1080/21505594.2020.1773107
27. Kochar DK, Das A, Kochar A, Middha S, Acharya J, Tanwar GS, et al. Thrombocytopenia in Plasmodium falciparum, Plasmodium vivax and mixed infection malaria: A study from Bikaner (Northwestern India). Platelets. 2010;21(8):623–7.
28. Buss I, Genton B, D’Acremont V. Aetiology of fever in returning travellers and migrants: A systematic review and meta-analysis. J Travel Med. 2020;27(8):1–12.
29. Supraja SSTEKK. Comparison of Hematological Parameters in Various Acute Febrile Illnesses. Int J Sci Res [Internet]. 2018;7(7):799–801. Available from: https://www.ijsr.net/archive/v7i7/ART20183954.pdf
30. Kotepui M, Phunphuech B, Phiwklam N, Chupeerach C, Duangmano S. Effect of malarial infection on haematological parameters in population near Thailand-Myanmar border. Malar J. 2014;13(1):1–7.
31. Gebreweld A, Erkihun Y, Feleke DG, Hailu G, Fiseha T. Thrombocytopenia as a Diagnostic Marker for Malaria in Patients with Acute Febrile Illness. J Trop Med. 2021;2021.
32. Ourives SS, Borges QI, Sampaio D, Cláudia E, Melo M, Souza RM De, et al. Analysis of the lymphocyte cell population during malaria caused by Plasmodium vivax and its correlation with parasitaemia and thrombocytopaenia. Malar J [Internet]. 2018;1–16. Available from: https://doi.org/10.1186/s12936-018-2443-x
33. Aggarwal A, Rath S, Shashiraj. Plasmodium vivax malaria presenting with severe thrombocytopenia. J Trop Pediatr. 2005;51(2):120–1.
34. Muley A, Lakhani J, Bhirud S, Patel A. Thrombocytopenia in plasmodium vivax malaria: How significant? J Trop Med. 2014;2014.
35. Punnath K, Dayanand KK, Chandrashekhar VN, Achur RN, Kakkilaya SB, Ghosh SK, et al. Association between inflammatory cytokine levels and anemia during Plasmodium falciparum and Plasmodium vivax infections in Mangaluru: A Southwestern Coastal Region of India. Trop Parasitol. 2019;9(2):98–107.
36. Gopalakrishnan NT, Papaiah S, Soman S, Upadhyaya K. A Clinicopathological Study of Thrombocytopenia in Malaria Cases with Its Evaluation in Different Types of Malaria. J Evol Med Dent Sci. 2021;10(33):2707–11.
37. Batool Y, Fatima S, Pervaiz G, Akhtar N, Asif M, Bashir F. Frequency of thrombocytopenia and its severity in patients of Malaria. Prof Med J. 2019;26(09):1398–403.
38. Margono S, Lubis B, Pasaribu S, Wijaya H, Pasaribu AP. The correlation between platelet count and parasite density in children with malaria infection. Asian Pacific J Trop Dis [Internet]. 2016;6(3):199–203. Available from: http://dx.doi.org/10.1016/S2222-1808(15)61013-1
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All articles published in JPTCP are licensed under Copyright Creative Commons Attribution-NonCommercial 4.0 International License.
Muhammad Numan Saleem
Department of Medicine, Hayatabad Medical Complex, Peshawar, Pakistan
Muhammad Younas
Department of Gastroenterology and Hepatology, Hayatabad Medical Complex, Peshawar
Roman Wazir
Department of Medicine, Sheikha Fatima Binte Mubarak Model Hospital, Sholam, Pakistan
Iqra
Department of Microbiology, Shaheed Benazir Bhutto Women University, Peshawar
Khalid Nawaz
Department of Medical Laboratory Technology, Institute of Paramedical Sciences, Khyber Medical University, Peshawar
Waqas Fazal
Department of Medicine, Hayatabad Medical Complex, Peshawar, Pakistan
Rizwanullah
Department of Medicine, Hayatabad Medical Complex, Peshawar, Pakistan
Ashish Sharma
Department of Medicine, Arogya hospital Pvt. Ltd, Galkot, Nepal
Waqar Khan
Department of Medicine, Hayatabad Medical Complex, Peshawar, Pakistan
Suleman Khan
Department of Medicine, Hayatabad Medical Complex, Peshawar, Pakistan